Preemptive Analgesia With OxyContin Versus Placebo Before Surgery for Long Bone Fractures

Fractures Clinical Trial

Official title:

Preemptive Analgesia With OxyContin Versus Placebo Before Surgery for Long Bone Fractures

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00254631
• Other study ID #: pre-oxy.CTIL
• Status: Completed
• Phase: Phase 4
• First received: November 15, 2005
• Last updated: February 4, 2015
• Start date: April 2007
• Est. completion date: December 2008

Study information

• Verified date: February 2015
• Source: Rambam Health Care Campus
• Contact: n/a
• Is FDA regulated: No
• Health authority: Israel: Israeli Health Ministry Pharmaceutical Administration
• Study type: Interventional

Clinical Trial Summary

We would like to check whether pre-operative administration of an oral controlled-release opioid formulation (Oxycodone hydrochloride (OxyContin)) could result in a clear effect of preemptive analgesia.

Description:

Preemptive analgesia is based on the concept of treating pain before inflicting the painful stimulus. One suggested mechanism is that transmission of pain signals is altered when the patient is treated before infliction of noxious stimulation. That prevents changes from happening in the nervous system, making transformation from acute to chronic pain ("central sensitization") less likely, and thus reducing post operative pain.

Clinically, good post operative pain control has been shown to be an effective method for hastening patient convalescence and discharge. It makes part of a general approach aiming to accelerate surgical recovery through earlier enteric feeding and ambulation

OxyContin tablets deliver Oxycodone at a controlled release manner, over 12 hours. After oral administration oral bioavailability is 60-87%.

A biphasic absorption pattern is observed, describing the initial (0.6 hours) and prolonged (6.9 hours) release of Oxycodone from the OxyContin tablets. Clinical analgesia is observed within 1 hour of administration.

We believe that this mode of oral drug release is more appropriate for the perioperative pain treatment of patients undergoing short to medium term operations: with timely administration, the first absorbed part of the drug reaches the plasma before infliction of the noxious stimuli, possibly counteracting primary sensitization, and the second part absorbed, acts on post operative ongoing pain, possibly counteracting more advanced stages of neuronal plasticity.

Study Hypothesis:

Our hypothesis is that post operative pain will be lowered by pre-operative administration of OxyContin. When comparing the two groups we will look for differences in observed parameters, especially VAS numbers, time to first analgesic request, post operative analgesic requirements, time to first oral intake and length of hospitalization, to confirm or deny our hypothesis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 65
• Est. completion date: December 2008
• Est. primary completion date: December 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

1. Patient consent.

2. Age 18 years to 60 years.

3. Isolated limb bone fracture/s.

Exclusion Criteria:

1. Patient refusal.

2. Age 61 years and older.

3. Known allergy to study medication.

4. Multiple bone fractures in different limbs.

5. Multiple trauma.

6. Oncological patients.

7. Respiratory depression / respiratory insufficiency / hypercarbia.

8. Acute bronchial asthma.

9. CNS depression / hallucinations.

10. Alzheimer / dementia.

11. Known convulsive disorder.

12. Prostate hypertrophy.

13. Paralytic ileus.

14. Renal dysfunction (plasma creatinine > 1.5).

15. Liver dysfunction.

16. Adrenocortical insufficiency.

17. Hypothyroidism.

18. Pancreatitis.

19. Pregnancy and lactating.

20. Drug abuse, current or in the past.

21. Alcohol abuse on admission to operating room.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Fractures
• Fractures, Bone

Intervention

Drug:
• Oxycodone hydrochloride

Locations

Country	Name	City	State
Israel	RAMBAM Health Care Campus	Haifa

Sponsors (1)

Lead Sponsor	Collaborator
Rambam Health Care Campus

Country where clinical trial is conducted

Israel, 

References & Publications (5)

Bach S, Noreng MF, Tjéllden NU. Phantom limb pain in amputees during the first 12 months following limb amputation, after preoperative lumbar epidural blockade. Pain. 1988 Jun;33(3):297-301. — View Citation

Capdevila X, Barthelet Y, Biboulet P, Ryckwaert Y, Rubenovitch J, d'Athis F. Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology. 1999 Jul;91(1):8-15. — View Citation

Code WE, Yip RW, Rooney ME, Browne PM, Hertz T. Preoperative naproxen sodium reduces postoperative pain following arthroscopic knee surgery. Can J Anaesth. 1994 Feb;41(2):98-101. — View Citation

Ong CK, Lirk P, Seymour RA, Jenkins BJ. The efficacy of preemptive analgesia for acute postoperative pain management: a meta-analysis. Anesth Analg. 2005 Mar;100(3):757-73, table of contents. — View Citation

Woolf CJ, Chong MS. Preemptive analgesia--treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg. 1993 Aug;77(2):362-79. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	post operative pain scores during first 24 hours (Visual analog scale)		24 hours after surgery	No
Secondary	Time to first analgesic request		at PACU	No
Secondary	Total other pain medications at first 24 hours post operative		first 24 hours after surgery	No
Secondary	Time to first oral intake		first 24 hours after surgery	No
Secondary	Length of hospitalization		after surgery	No